(Q37324885)

19 August 2017

1 reference

title

Churg-Strauss syndrome: 2005-2008 update (English)

1 reference

19 August 2017

main subject

Churg-Strauss syndrome

1 reference

Rafael G Grau

1

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Current Rheumatology Reports

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

453-458

1 reference

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0074-X

Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0074-X

Coronary involvement in the Churg-Strauss syndrome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-008-0074-X

Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

21 January 2018

1 reference

12 December 2020

Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases

1 reference

12 December 2020

Central retinal artery occlusion in an ANCA negative Churg-Strauss syndrome patient

1 reference

12 December 2020

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome presenting with salivary gland enlargement and respiratory distress

1 reference

12 December 2020

Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma

1 reference

12 December 2020

Renal involvement in Churg-Strauss syndrome

1 reference

12 December 2020

Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome

1 reference

12 December 2020

Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients

1 reference

12 December 2020

Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis

1 reference

12 December 2020

Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.

1 reference

12 December 2020

Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome.

1 reference

12 December 2020

Administration of anti-IgE to a Churg-Strauss syndrome patient

1 reference

12 December 2020

Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome

1 reference

12 December 2020

One year administration of anti-IgE to a patient with Churg-Strauss syndrome

1 reference

12 December 2020

Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma

1 reference

12 December 2020

Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

1 reference

12 December 2020

Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA).

1 reference

12 December 2020

Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

1 reference

12 December 2020

Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists

1 reference

12 December 2020

Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis.

1 reference

12 December 2020

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

1 reference

12 December 2020

Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome

1 reference

12 December 2020

Etanercept plus standard therapy for Wegener's granulomatosis

1 reference

12 December 2020

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients

1 reference

12 December 2020

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

12 December 2020

Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy

1 reference

12 December 2020

Unusual presentation of temporal bone involvement in Churg-Strauss syndrome

1 reference

12 December 2020

Targeting B lymphocytes as therapy for ANCA-associated vasculitis

1 reference

12 December 2020

Are environmental factors important in primary systemic vasculitis? A case-control study

1 reference

12 December 2020

Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients

1 reference

12 December 2020

Rituximab in Churg-Strauss syndrome.

1 reference

12 December 2020

Churg-Strauss syndrome: just one disease entity?

1 reference

12 December 2020

Churg-Strauss syndrome presenting with massive pericardial effusion.

1 reference

12 December 2020

Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome

1 reference

12 December 2020

Conjunctival involvement in Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss vasculitis in a patient treated with omalizumab

1 reference

12 December 2020

Churg-Strauss syndrome: update on recent developments

1 reference

12 December 2020

Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy

1 reference

12 December 2020

Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis

1 reference

12 December 2020

Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales

1 reference

12 December 2020

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

12 December 2020

Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}.

1 reference

12 December 2020

Cerebral venous thrombosis as a rare onset of Churg-Strauss syndrome

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

1 reference

12 December 2020

Multiple tracheobronchial mucosal lesions in two cases of Churg-Strauss syndrome

1 reference

12 December 2020

Acute painless monocular visual loss due to central retinal artery occlusion in a patient with Churg-Strauss vasculitis.

1 reference

12 December 2020

Asthma drug use and the development of Churg-Strauss syndrome (CSS).

1 reference

12 December 2020

Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome.

1 reference

12 December 2020

Increased serum high mobility group box-1 level in Churg-Strauss syndrome

1 reference

12 December 2020

Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome

1 reference

12 December 2020

Discoidin domain receptor 1 contributes to eosinophil survival in an NF-kappaB-dependent manner in Churg-Strauss syndrome

1 reference

12 December 2020

Cardiac involvement in the Churg-Strauss syndrome

1 reference

12 December 2020

Acute coronary syndrome associated with Churg-Strauss syndrome.

1 reference

12 December 2020

Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus

1 reference

12 December 2020

Associations of Churg-Strauss syndrome with the HLA–DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody–associated vasculitides: Comment on the article by Vaglio et al

1 reference

12 December 2020

Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity

1 reference

12 December 2020

Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment

1 reference

12 December 2020

10.1007/S11926-008-0074-X

Identifiers

DOI

1 reference

19 August 2017

1 reference